When Your Body Stops Warning You of Danger
Most people with type 1 diabetes know the feeling: the shakiness, the sweating, the sudden sense that something is wrong. These symptoms are the body's alarm system — triggered when blood sugar drops too low. They are designed to make you stop, eat something, and recover.
But for some people with type 1 diabetes, that alarm system goes silent.
A Problem Inside the Problem
Hypoglycemia (hy-po-gly-SEE-mee-a) — low blood sugar — is the most dangerous short-term complication of type 1 diabetes. Every insulin injection carries the risk of pushing blood sugar too low.
In healthy people, the body responds to low blood sugar with a cascade of hormones — epinephrine (adrenaline), cortisol, and glucagon — that raise blood glucose back up and trigger the symptoms that warn you to eat. It's like a fire alarm going off in your body.
But after years of repeated low blood sugar episodes, some people with type 1 diabetes develop a condition called impaired awareness of hypoglycemia (IAH). The alarm stops going off. They can drop into a dangerously low range without feeling any symptoms — and without being able to take action in time.
IAH affects roughly 25% of people with long-standing type 1 diabetes, and it dramatically increases the risk of severe, life-threatening hypoglycemic events.
What Scientists Thought They Knew
Previous research used standard brain imaging to identify which regions of the brain are affected by low blood sugar. Certain areas — particularly the thalamus (a relay hub for sensory signals), the striatum (involved in movement and reward), and the insula (tied to interoception, or the body's awareness of its internal state) — showed changes.
But those earlier studies mostly looked at static snapshots of brain activity. They didn't examine the dynamic, moment-to-moment relationship between blood flow in the brain and the hormones circulating in the bloodstream during a low blood sugar episode.
This new study set out to change that.
An Experiment Built for Precision
Researchers enrolled 81 participants in three groups: 26 healthy adults without diabetes (controls), 30 people with type 1 diabetes who still had normal awareness of low blood sugar, and 25 people with type 1 diabetes who had lost that awareness (IAH group).
Each person underwent a carefully controlled procedure called a hyperinsulinemic stepped clamp (hy-per-in-soo-lin-EE-mic). This involved giving participants insulin to lower blood sugar to a specific target — 50 mg/dL, a level that reliably triggers a low blood sugar response — while the researchers controlled the drop precisely.
At the same time, participants underwent a specialized type of MRI called arterial spin-labeling. This technique measures blood flow through the brain in real time, without using a contrast dye. Think of it as watching the brain's irrigation system in action, moment by moment.
Blood samples were collected repeatedly throughout the procedure to measure cortisol, epinephrine, norepinephrine, and glucagon — the key hormones involved in the body's response to low blood sugar.
In healthy controls, low blood sugar triggered a strong surge in blood flow to the thalamus, striatum, and insula — the regions responsible for perceiving internal body states and signaling distress. This is the brain saying: "Something is wrong, pay attention."
At the same time, in healthy people, the natural rhythmic oscillations (regular waves) of blood flow driven by the sympathetic nervous system became suppressed. Think of it as the body turning down the background noise so the alarm signal can be heard more clearly.
People with type 1 diabetes retained the blood flow surge to those brain regions — but they failed to suppress the background oscillations. Their brains couldn't quiet the noise even as the alarm was ringing.
This doesn't yet translate into a treatment — but it reveals a new target for understanding why the alarm system degrades.
In people with IAH — those who had lost the ability to feel low blood sugar — the blood flow surge itself was blunted. The alarm didn't just have background noise. It was quieter to begin with.
And the relationship between stress hormones and brain blood flow was reversed. In healthy people, higher cortisol and epinephrine correlated with higher brain blood flow — a coherent system where the hormone signal and the brain response move together. In IAH patients, that relationship was disrupted and distorted.
This Is Where Things Get Interesting
The researchers describe this as a "qualitatively distinct neurovascular phenotype" — meaning people with IAH don't just have a milder version of normal. They have a fundamentally different pattern of how the brain and the stress hormone system interact.
This distinction matters. It suggests that IAH is not simply the brain adapting to repeated low blood sugar by turning down its sensitivity — it may involve a deeper rewiring of how the brain and the body's endocrine system communicate during metabolic stress.
If you have type 1 diabetes and feel like your ability to sense low blood sugar has diminished over time, tell your endocrinologist. IAH is diagnosable and manageable. Strategies include strict avoidance of low blood sugar for several weeks (which can partially restore awareness), continuous glucose monitoring (CGM) with alerts set at a higher threshold, and in some cases, closed-loop insulin delivery systems (sometimes called artificial pancreas technology).
This study doesn't offer a new treatment, but it deepens our understanding of why IAH develops — which is the first step toward eventually reversing it.
Limitations to Keep in Mind
This was a carefully controlled laboratory study — conditions were highly artificial compared to real life. Blood sugar was lowered under very specific, monitored conditions that don't replicate the unpredictable nature of daily diabetes management. The study enrolled 81 participants — a reasonable number for this type of research, but not large enough to capture all the variation that exists among people with type 1 diabetes. The study also cannot determine whether the brain changes caused IAH, or whether IAH caused the brain changes.
Understanding the neurovascular signature of IAH opens up new research directions. Scientists can now investigate whether treatments that restore hormone-brain coupling — through structured avoidance of lows, new drug targets, or neuromodulation (therapies that directly influence brain activity) — can reverse the changes seen in IAH patients. That research is still in early stages. But for the millions of people with type 1 diabetes navigating the daily risk of severe low blood sugar, this study brings the biology of a dangerous condition into sharper focus.